Editorial. Precision oncology in checkpoint immunotherapy: leveraging predictive biomarkers for personalized treatment
| dc.contributor.author | Dlamini, Zodwa | |
| dc.contributor.author | Kahraman, Abdullah | |
| dc.contributor.author | Chatziioannou, Aristotelis | |
| dc.date.accessioned | 2026-01-30T09:24:16Z | |
| dc.date.issued | 2026 | |
| dc.identifier.doi | 10.3389/fimmu.2025.1772930 | |
| dc.identifier.issn | 1664-3224 | |
| dc.identifier.uri | https://irf.fhnw.ch/handle/11654/55369 | |
| dc.identifier.uri | https://doi.org/10.26041/fhnw-15213 | |
| dc.language.iso | en | |
| dc.publisher | Frontiers Research Foundation | |
| dc.relation.ispartof | Frontiers in Immunology | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.ddc | 610 - Medizin und Gesundheit | |
| dc.title | Editorial. Precision oncology in checkpoint immunotherapy: leveraging predictive biomarkers for personalized treatment | |
| dc.type | 01A - Beitrag in wissenschaftlicher Zeitschrift | |
| dc.volume | 16 | |
| dspace.entity.type | Publication | |
| fhnw.InventedHere | Yes | |
| fhnw.ReviewType | Anonymous ex ante peer review of a complete publication | |
| fhnw.oastatus.aurora | Version: Published *** Embargo: None *** Licence: CC BY *** URL: https://v2.sherpa.ac.uk/id/publication/22701 | |
| fhnw.openAccessCategory | Gold | |
| fhnw.pagination | 1-4 | |
| fhnw.publicationState | Published | |
| fhnw.targetcollection | e9f5c209-f87b-418f-9329-653451334860 | |
| relation.isAuthorOfPublication | a6b12c58-f330-4302-9e09-78e47baf80d6 | |
| relation.isAuthorOfPublication.latestForDiscovery | a6b12c58-f330-4302-9e09-78e47baf80d6 |
Dateien
Originalbündel
1 - 1 von 1
Lizenzbündel
1 - 1 von 1
Lade...
- Name:
- license.txt
- Größe:
- 2.66 KB
- Format:
- Item-specific license agreed upon to submission
- Beschreibung: